| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 74296 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
79 |
wyh |
2024-12-19 |
| 74297 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
102 |
h |
2024-12-19 |
| 74298 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
78 |
wyh |
2024-12-19 |
| 74299 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
174 |
h |
2024-12-19 |
| 74300 |
DOTA-多柔比星 DOTA-DOX |
107 |
h |
2024-12-19 |
| 74301 |
聚(HPMA)-c(RGDyK)-DOTA |
58 |
h |
2024-12-19 |
| 74302 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
80 |
h |
2024-12-19 |
| 74303 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
73 |
zyl |
2024-12-19 |
| 74304 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
108 |
h |
2024-12-19 |
| 74305 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
120 |
h |
2024-12-19 |
| 74306 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
154 |
h |
2024-12-19 |
| 74307 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-F(ab)2-曲妥珠单抗 |
80 |
h |
2024-12-19 |
| 74308 |
DOTA-MG11(DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp)DOTA肽缀合物 |
105 |
h |
2024-12-19 |
| 74309 |
AcLys-PABC-VC-Aur0101， cas:1438851-17-2，ADC定制 |
134 |
wyh |
2024-12-19 |
| 74310 |
cas:107348-47-0，2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate ADC抗体偶联药物 |
71 |
zyl |
2024-12-19 |
| 74311 |
SMCC-DM4 ， cas:1228105-52-9，ADC定制 |
72 |
wyh |
2024-12-19 |
| 74312 |
cas:1639939-40-4 Mal-Val-Ala-PAB-PNP |
74 |
zyl |
2024-12-19 |
| 74313 |
MA-PEG8-VA-PAB-SG3199，ADC定制 |
89 |
wyh |
2024-12-19 |
| 74314 |
Acid-PEG4-Val-Cit-PAB-MMAE |
67 |
zyl |
2024-12-19 |
| 74315 |
MC-Val-Cit-PAB-Indibulin，cas:2055896-95-0，ADC定制 |
82 |
wyh |
2024-12-19 |
| 74316 |
cas:1096584-62-1 Mal-Val-Cit-PAB-PNP |
79 |
zyl |
2024-12-19 |
| 74317 |
cas:863971-53-3 Fmoc-Val-Cit-PAB-PNP |
79 |
zyl |
2024-12-19 |
| 74318 |
MC-Sq-Cit-PAB-Dolastatin10 ，cas:1941168-65-5，ADC定制 |
95 |
wyh |
2024-12-19 |
| 74319 |
Mal-PEG2-Val-Cit-PAB-OH ADC抗体偶联药物 |
86 |
zyl |
2024-12-19 |
| 74320 |
N3-PEG4-DYKDDDD-Doxorubicin，ADC定制 |
103 |
wyh |
2024-12-19 |
| 74321 |
MA-vc-PAB-DM1 cas:1464051-44-2 |
66 |
zyl |
2024-12-19 |
| 74322 |
DBCO-PEG4-VC-PAB-DMAE-Duocarmycin SA |
87 |
zyl |
2024-12-19 |
| 74323 |
VC-PAB-DMAE-PNU159682 ADC抗体偶联药物 |
83 |
zyl |
2024-12-19 |
| 74324 |
MC-GGFG-DX8951 cas:1600418-29-8 |
75 |
zyl |
2024-12-19 |
| 74325 |
DOTA-NGR NGR肽偶联1,4,7,10-四氮杂环十二烷-N,N’,N”,N”’-四乙酸(DOTA) |
90 |
h |
2024-12-19 |
| 74326 |
N3-PEG4-vc-PAB-Doxorubicin 叠氮PEG修饰维生素C-阿霉素的介绍 |
185 |
zyl |
2024-12-19 |
| 74327 |
DOTA-Ahx-(d-Lys6-GnRH1)DOTA偶联的d-Lys6-GnRH肽 |
88 |
h |
2024-12-19 |
| 74328 |
DOTA-porphyrin 双功能螯合剂DOTA偶联5-(对-氨基-丙烯-氧苯基)-10,15,20-三-(对-羧基-甲基-烯-氧苯基)卟啉 |
117 |
h |
2024-12-19 |
| 74329 |
VC-SECO DUBA analogue，ADC定制 |
92 |
wyh |
2024-12-19 |
| 74330 |
DOTA-H-Lys(Boc)-OH-SWCNTs 赖氨酸胺手柄功能化的单壁碳纳米管偶联DOTA螯合剂 |
89 |
h |
2024-12-19 |
| 74331 |
[DOTA-A1]-ZHER2:S1 抗HER2 ZHER2:S1亲和体分子缀合DOTA |
112 |
h |
2024-12-19 |
| 74332 |
Vc-MMAD cas:1401963-17-4的结构式 |
72 |
zyl |
2024-12-19 |
| 74333 |
DOTA-E(c(RGDfK))大环DOTA偶联双环肽E[c(RGDfK)] |
96 |
h |
2024-12-19 |
| 74334 |
CL2A-SN38，cas:1279680-68-0，ADC定制 |
163 |
wyh |
2024-12-19 |
| 74335 |
DOTA-gluBBN DOTA缀合铃蟾肽类似物 |
74 |
h |
2024-12-19 |
| 74336 |
DOTA-GSG-KCCYSL DOTA缀合物ErbB-2靶向肽KCCYSL |
150 |
h |
2024-12-19 |
| 74337 |
MC-MMAF ， cas:863971-19-1，ADC定制 |
111 |
wyh |
2024-12-19 |
| 74338 |
TCO-PEG4-Fmoc-Gly-Gly-Gly-ADC连接子 |
135 |
zyl |
2024-12-19 |
| 74339 |
模拟肽4-[2-(3,4,5,6-四氢嘧啶-2-基氨基)乙氧基]苯甲酰基-2-[N-(3-氨基-新戊-1-氨基甲酰基)]-氨乙基磺酰基-氨基-β-丙氨酸(IAC)缀合DOTA |
84 |
h |
2024-12-19 |
| 74340 |
DOTA-chCE7 DOTA标记的糖基化单克隆抗L1-CAM抗体chCE7 |
97 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询